Park Ha Biological Technology Co Ltd (BYAH) Stock AnalysisBYAHPark Ha Biological Technology Co Ltd

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market. It operates in the Consumer Non-Cyclicals sector.

While Park Ha Biological Technology Co Ltd (BYAH) has shown a recent 5-day price increase of 5.45%, its year-to-date decline of 96.59% raises significant concerns. The current price of $2.32 is far below its 200-day simple moving average of $12.405, indicating a bearish trend. The RSI is at 44.236, suggesting it is neither overbought nor oversold, but the negative forward P/E ratio of 0 and the high price-to-sales ratio of 18.10441 indicate potential valuation issues. Therefore, it may be prudent to hold off on buying until clearer positive trends emerge.